Soleil Securities
http://www.soleilgroup.com/index.shtmlSoleil Securities provides equity research for institutional investors.
-
Soleil Securities Reiterates a 'Buy' on Cephalon (CEPH); Solid Q1 Likely to Provide a Catalyst
-
Soleil Says Buy Cephalon (CEPH) 'On Weakness' Following FDA's Decision on Nuvigil
-
Soleil Securities Reiterates a 'Buy' on Cephalon (CEPH); Near-Term Catalysts Likely to Aid Shares
-
Soleil Securities Reiterates a 'Buy' on Cephalon (CEPH); Raises Estimates on Earlier Treanda Front-Line Compendia Listing
-
Soleil Securities Reiterates a 'Buy' Rating on Cephalon (CEPH); Treanda to be in Focus Today
-
Morning Movers 11/23: ABIO, SEED, FIF, FNET, DDRX, JOBS Higher; BBI, CGA, BOFL, CEPH Lower
-
Soleil Securities Reiterates a 'Buy' on Cephalon (CEPH)
-
Soleil Securities Initiates Coverage on Cephalon (CEPH) with a Buy
-
Soleil Upgrades Cephalon (CEPH) to Buy